Treatments

Transcranial Magnetic Stimulation (TMS) has been cleared or approved by the FDA or European CE for the following conditions (as of early 2024)

1. Major Depressive Disorder (MDD)
- FDA: Approved for treatment-resistant depression (since 2008).
- CE: Approved for MDD.

2. Obsessive-Compulsive Disorder (OCD)
- FDA: Cleared for OCD (2018, via Brainsway Deep TMS™).
- CE: Approved for OCD.

3. Migraine with Aura
- FDA: Cleared for acute treatment (2013, eNeura sTMS device).

4. Smoking Cessation (Short-Term Aid)
- FDA: Cleared as an adjunct for short-term smoking cessation (2020, Brainsway Deep TMS™).

5. Neuropathic Pain
- CE: Approved for chronic neuropathic pain management.

6. Parkinson’s Disease (Motor Symptoms)
- CE: Approved to address motor symptoms (e.g., bradykinesia, rigidity).

7. Stroke Rehabilitation (Motor Recovery)
- CE: Approved for post-stroke motor recovery.

8. Tinnitus
- CE: Approved for chronic subjective tinnitus.

9. Schizophrenia (Negative Symptoms)
- CE: Approved for managing negative symptoms (e.g., apathy, social withdrawal).

Apart from the approved conditions, TMS can also be used off-label for various other conditions, such as:

• Anxiety Disorders, such as Generalized Anxiety, or Phobia
• Refractory Auditory Hallucinations
• Alzheimer’s Dementia
• And many others, using a case-by-case, collaborative decision-making process.